The Effect of Stellate Ganglion Block on Insomnia Patients: a Pre - and Post Control Experiments
Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A prospective study was conducted on Insomnia Patients. All the patients were provided with Stellate Ganglion Block. The quality of sleep was evaluated to see if Stellate Ganglion Block can improve Insomnia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Insomnia patients with the ages over 18.
• Meeting the diagnostic criteria for chronic insomnia as per the International Classification of Sleep Disorders (ICSD) or the Diagnostic and Statistical Manual of Mental Disorders (DSM).
• Experiencing insomnia symptoms persistently for at least three months.
• Not currently using or ceased using medication for insomnia for at least four weeks.
• Willing to undergo Stellate Ganglion Block treatment and participate in the study.
Locations
Other Locations
Republic of Korea
Center Rehabilitation Hospital
RECRUITING
Seoul
Contact Information
Primary
Qianyun Lu, Master
luqianyun@126.com
15333866454
Backup
Weiji Zhao, Master
zwjww2009@163.com
17839973473
Time Frame
Start Date: 2024-02-28
Estimated Completion Date: 2024-06
Participants
Target number of participants: 50
Treatments
Experimental: Stellate Ganglion Block Group
Stellate Ganglion Block Group will be given Stellate Ganglion Block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g), once a day
Related Therapeutic Areas
Sponsors
Leads: Zeng Changhao